henk vergunst
henk vergunst
Unknown affiliation
Verified email at cwz.nl
Title
Cited by
Cited by
Year
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ...
European urology 63 (4), 597-603, 2013
4772013
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
LA Kiemeney, S Thorlacius, P Sulem, F Geller, KKH Aben, SN Stacey, ...
Nature genetics 40 (11), 1307-1312, 2008
4372008
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer
GHJM Leyten, D Hessels, SA Jannink, FP Smit, H de Jong, EB Cornel, ...
European urology 65 (3), 534-542, 2014
3402014
Three-Tesla magnetic resonance–guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound …
CMA Hoeks, MG Schouten, JGR Bomers, SP Hoogendoorn, ...
European urology 62 (5), 902-909, 2012
2752012
Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction
MR van BALKEN, V VANDONINCK, KWH GISOLF, H VERGUNST, ...
The Journal of urology 166 (3), 914-918, 2001
2372001
Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score
L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ...
European urology 70 (5), 740-748, 2016
2122016
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer
DM Somford, EH Hamoen, JJ Fütterer, JP Van Basten, ...
The Journal of urology 190 (5), 1728-1734, 2013
1562013
Identification of a candidate gene panel for the early diagnosis of prostate cancer
GHJM Leyten, D Hessels, FP Smit, SA Jannink, H de Jong, WJG Melchers, ...
Clinical Cancer Research 21 (13), 3061-3070, 2015
1352015
The use of electrical devices for the treatment of bladder dysfunction: a review of methods
MR van BALKEN, H Vergunst, BLH Bemelmans
The Journal of urology 172 (3), 846-851, 2004
1342004
Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites
HM Kluger, CR Zito, ML Barr, MK Baine, VLS Chiang, M Sznol, DL Rimm, ...
Clinical Cancer Research 21 (13), 3052-3060, 2015
1302015
Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain
MR Van Balken, V Vandoninck, BJ Messelink, H Vergunst, ...
European urology 43 (2), 158-163, 2003
1072003
Prognostic factors for successful percutaneous tibial nerve stimulation
MR Van Balken, H Vergunst, BLH Bemelmans
European urology 49 (2), 360-365, 2006
982006
Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance–guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer …
CMA Hoeks, DM Somford, IM van Oort, H Vergunst, JR Oddens, GA Smits, ...
Investigative radiology 49 (3), 165-172, 2014
952014
Comparison of three schedules of intravesical epirubicin in patients with non–muscle-invasive bladder cancer
K Hendricksen, WPJ Witjes, JG Idema, JJM Kums, OB van Vierssen Trip, ...
European urology 53 (5), 984-991, 2008
922008
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response
AG van der Heijden, PMJ Moonen, EB Cornel, H Vergunst, TM de Reijke, ...
The Journal of urology 176 (4), 1349-1353, 2006
872006
Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma
T Kawai, K Yasuchika, T Ishii, H Katayama, EY Yoshitoshi, S Ogiso, S Kita, ...
Clinical cancer research 21 (13), 3081-3091, 2015
842015
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer
DM Somford, CM Hoeks, CA Hulsbergen-van de Kaa, T Hambrock, ...
Investigative radiology 48 (3), 152-157, 2013
662013
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy
D Yakar, T Hambrock, H Huisman, CA Hulsbergen-van de Kaa, E van Lin, ...
Investigative radiology 45 (3), 121-125, 2010
662010
MR imaging–guided focal cryoablation in patients with recurrent prostate cancer
JGR Bomers, D Yakar, CG Overduin, JPM Sedelaar, H Vergunst, ...
Radiology 268 (2), 451-460, 2013
642013
Quality of life after prostate cancer treatments in patients comparable at baseline
JJ van Tol-Geerdink, JWH Leer, IM Van Oort, E Van Lin, PC Weijerman, ...
British Journal of cancer 108 (9), 1784-1789, 2013
582013
The system can't perform the operation now. Try again later.
Articles 1–20